ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,424.80
      0.12%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.785
      1.05%
      Bitcoin
      65,082.10
      -2.11%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      10/24/20238:00AMGlobeNewswire Inc.Esperion to Report Third Quarter 2023 Financial Results on November 7NASDAQ:ESPREsperion Therapeutics Inc
      10/05/20239:00AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ESPREsperion Therapeutics Inc
      09/21/20235:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/20/20233:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      09/12/202310:15AMGlobeNewswire Inc.American College of Cardiology Program to Increase Cholesterol ScreeningsNASDAQ:ESPREsperion Therapeutics Inc
      08/28/20238:00AMGlobeNewswire Inc.Esperion to Participate in H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      08/26/202311:00AMGlobeNewswire Inc.Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology Congress 2023NASDAQ:ESPREsperion Therapeutics Inc
      08/24/20239:29AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ESPREsperion Therapeutics Inc
      08/21/20234:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      08/18/20233:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      08/11/20238:00AMGlobeNewswire Inc.Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023NASDAQ:ESPREsperion Therapeutics Inc
      08/09/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      08/08/20234:15PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      08/01/20239:02AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ESPREsperion Therapeutics Inc
      08/01/20238:51AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ESPREsperion Therapeutics Inc
      08/01/20237:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ESPREsperion Therapeutics Inc
      08/01/20236:00AMGlobeNewswire Inc.Esperion Reports Second Quarter 2023 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      07/24/20238:00AMGlobeNewswire Inc.Esperion to Participate in BTIG Virtual Biotechnology Conference 2023NASDAQ:ESPREsperion Therapeutics Inc
      07/20/20234:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      07/19/20233:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ESPREsperion Therapeutics Inc
      07/17/20236:00AMGlobeNewswire Inc.Esperion to Report Second Quarter 2023 Financial Results on August 1NASDAQ:ESPREsperion Therapeutics Inc
      07/07/20238:00AMGlobeNewswire Inc.Esperion to Present Additional Data from the CLEAR Outcomes Study on CVD Prevention at the American Society for Preventive Cardiology (ASPC) Congress 2023NASDAQ:ESPREsperion Therapeutics Inc
      06/28/20238:00AMGlobeNewswire Inc.Esperion Announces Submission of Application for Expanded Indication with the European Medicines Agency (EMA) for NILEMDO® (bempedoic acid) Tablet and NUSTENDI® (bempedoic acid and ezetimibe) TabletNASDAQ:ESPREsperion Therapeutics Inc
      06/26/20236:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      06/24/20232:30PMGlobeNewswire Inc.Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific SessionsNASDAQ:ESPREsperion Therapeutics Inc
      06/21/20233:25PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ESPREsperion Therapeutics Inc
      06/16/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/16/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/16/20234:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/16/20234:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR